CSIMarket Company Name, Ticker, Competitors, else..
Zoetis Inc   (NYSE: ZTS)
Other Ticker:  
 


 

Zoetis Inc

ZTS's Financial Statements and Analysis



Zoetis Inc reported in the third quarter of 2025 net earnings per share of $1.63 an increase by 8.67 % year on year from $1.50 and an improvement of 1.24 % from $1.61 realized in II. Quarter (Jun 30 2025).


third quarter of 2025
Earnings Per Share Revenues
$ 1.63 $  2,400 Mill
$+0.13     +8.67 % $+12M     +0.5 %



Zoetis Inc 's Revenue rose by 0.5 % in third quarter of 2025 (Sep 30 2025) year on year, to $2,400 million and declined by -2.44 % sequentially.


Zoetis Inc is

More on ZTS's Income Statement



Zoetis Inc 's net income of $721.000 million in the third quarter of 2025 increased by 4.19 % from net earnings of $692.000 million achieved in III. Quarter a year ago.

Sequentially net earnings grew by 0.42 % from net income of $718.000 million realized in previous quarter.

More on ZTS's Growth




Zoetis Inc Inventories
Inventories grew by 2.03 % to $2,465 million from III. Quarter a year ago, sequentially inventories rose by 1.07 %. ZTS's Cash flow In the third quarter of 2025 company's net cash flow was $649 million, capital expenditures grew by -167-20.36%, to $-133 millions compare to same quarter a year ago

More on ZTS's Cash flow Statement


Zoetis Inc payed out dividend of $2.00 per share in last 52 weeks representing 33.67 % of net earning per share in trailing twelve-month period.

During the same period Zoetis Inc earned $ 6.58 cash per share, on a free-cash flow basis 110.76 % of net earning per share.

Book value grew by 9.02 % sequentially to $12.18 per share, 10.75% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 3.60 per share from $ 2.57.

Company repurchased 2.30 million shares or 0.52 % in Sep 30 2025.
Interest Coverage Ratio was 16.42. Debt Coverage Ratio was 0.53.

• More on ZTS's Dividends

 Market Capitalization (Millions) 53,547
 Shares Outstanding (Millions) 443
 Total Debt (Millions $) 7,069
 Revenue (TTM) (Millions $) 9,397
 Net Income (TTM) (Millions $) 2,651
 Cash Flow (TTM) (Millions $) 370
 Capital Exp. (TTM) (Millions $) -676
 Dividend TTM ($) 2 $
 Dividend Yield TTM (%) 1.66 %
 Employees (TTM) $ 14,100




Zoetis Inc payed out dividend of $2.00 per share in the last 52 weeks representing 33.67 % of net earning per share in trailing twelve-month period.

During the same period Zoetis Inc had $ 6.58 cash flow per share, on a free-cash flow basis 110.76 % of net earning per share.

Book value grew by 9.02 % sequentially to $12.18 per share, 10.75% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 3.60 per share from $ 2.57.

Company repurchased 2.30 million shares or 0.52 % in Sep 30 2025.
Interest Coverage Ratio was 16.42. Debt Coverage Ratio was 0.53.

• More on ZTS's Balance Sheets

 Market Capitalization (Millions) 53,547
 Shares Outstanding (Millions) 443
 Total Debt (Millions $) 7,069
 Revenue (TTM) (Millions $) 9,397
 Net Income (TTM) (Millions $) 2,651
 Cash Flow (TTM) (Millions $) 370
 Capital Exp. (TTM) (Millions $) -676
 Dividend TTM ($) 2 $
 Dividend Yield TTM (%) 1.66 %
 Employees (TTM) $ 14,100
   


  News about Zoetis Inc Earnings

Zoetis Inc. Beats Market Volatility with Impressive Growth in Revenue and Profits 2.

Despite a slight decline in Zoetis Inc. (NYSE: ZTS) shares during April 2024, the company has shown remarkable resilience in the face of market volatility. Over the course of the last five trading days, Zoetis Inc. shares recorded a solid gain of 6.78%, highlighting the market's positive response to the company's financial results. However, it's worth noting that Zoetis Inc. shares currently trade only 10.3% above their 52-week low. This suggests that there may still be some uncertainty in investor sentiment.
While the drop in shares might raise concerns for some, it is essential to analyze the overall context in which this occurred. Zoetis Inc. has achieved remarkable revenue and operational growth, pos...

Zoetis Inc. Dominates Fourth Quarter 2023 Earnings Season with Exceptional Financial Performance

As a financial analyst for the , I am pleased to interpret the recent financial results of Zoetis Inc., a major pharmaceutical preparations company that specializes in animal health. Looking at the fiscal span ending December 31, 2023, it is evident that Zoetis Inc. has made significant strides in terms of revenue and earnings growth.
The company reported a revenue increase of 8.48% to $2.21 billion, compared to $2.04 billion in the prior year. This impressive revenue growth outperformed its industry peers, who only saw an average increase of 3.08% during the same period. Additionally, Zoetis Inc. posted earnings growth of 15.51% to $1.14 per share, up from $0.99 in the previous year. These results indic...

Zoetis Inc. Dominates Market with Impressive 7% Revenue Growth in Third Quarter

Zoetis Inc. Reports Strong Quarter with Revenue Increase of 7%
Zo...

Zoetis Inc. Sees Remarkable 29.46% Surge in Earnings, Reinforces Dominance in Animal Health Industry

Zoetis Inc. i...

Zoetis Inc Faces Income Decline in Q1 2023, but Investors Should Remain Optimistic

Investors in the stock market should keep a close eye on Zoetis Inc, a leading name in the healthcare sector. Although the company achieved a return on invested assets (ROI) of 18.34% in its first quarter of 2023, which is below its average ROI, this decline should not discourage investors. Returns on investments can fluctuate due to several factors, and it is essential to consider the broader picture.
While the ROI fell when compared to the fourth quarter of 2022, Zoetis Inc saw net income growth of 19.78%. Additionally, other companies in the healthcare sector had a higher ROI than Zoetis Inc. However, it is worth noting that ...


Date modified: 2025-11-05T06:19:00+00:00




Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.